6/24/2024 | SP | New Issue: JPMorgan sells $588,000 capped accelerated barrier notes on Gilead, Target
|
4/4/2024 | SP | New Issue: CIBC sells $2.75 million contingent coupon autocallable barrier notes on three stocks
|
9/14/2023 | SP | New Issue: JPMorgan prices $350,000 7.2% autocallable yield notes linked to Gilead
|
8/31/2023 | SP | New Issue: UBS sells $2.33 million capped trigger gears on basket of 40 stocks
|
8/15/2023 | SP | New Issue: JPMorgan prices $1.29 million trigger autocallable contingent yield notes on Gilead Sciences
|
3/9/2023 | SP | New Issue: Citigroup prices $2.42 million contingent income autocallables linked to Gilead
|
3/1/2023 | SP | New Issue: UBS prices $545,000 trigger autocallable contingent yield notes on Gilead Sciences
|
2/15/2023 | SP | New Issue: UBS prices $1.93 million contingent income autocallable securities on Gilead
|
2/8/2023 | SP | New Issue: JPMorgan prices $1.4 million contingent income autocallables on Gilead
|
11/2/2022 | SP | New Issue: UBS prices $945,000 trigger autocallable contingent yield notes on Gilead Sciences
|
11/1/2022 | SP | New Issue: JPMorgan prices $241,000 autocallable contingent interest notes on pharma stocks
|
10/28/2022 | SP | New Issue: Citigroup prices $305,000 12% autocallable contingent coupon equity notes on Gilead
|
10/25/2022 | SP | New Issue: GS Finance sells $494,000 of 8% autocallable fixed-coupon notes on Gilead
|
10/1/2022 | SP | New Issue: Credit Suisse sells $1.07 million contingent coupon autocallable yield notes on two stocks
|
8/29/2022 | SP | New Issue: JPMorgan prices $397,000 8.25% autocallable yield notes linked to Gilead
|
8/24/2022 | SP | New Issue: Citigroup prices $3.38 million contingent income autocalls on Gilead
|
6/8/2022 | SP | New Issue: JPMorgan prices $750,000 autocallable contingent interest notes on pharma stocks
|
5/16/2022 | SP | New Issue: HSBC sells $526,000 callable contingent income barrier notes on four stocks
|
4/26/2022 | SP | New Issue: Credit Suisse sells $1.75 million accelerated barrier notes on basket
|
2/17/2022 | SP | New Issue: Citigroup prices $4.17 million contingent income autocalls on Gilead
|
2/11/2022 | SP | New Issue: UBS prices $1 million trigger autocallable contingent yield notes on three stocks
|
1/14/2022 | SP | New Issue: Citi prices $1.5 million autocallable contingent coupon equity notes on two stocks
|
1/3/2022 | SP | New Issue: JPMorgan prices $7.67 million contingent income autocallables on Gilead Sciences
|
12/17/2021 | SP | New Issue: Credit Suisse sells $3.83 million contingent coupon autocallable yield notes on stocks
|
12/7/2021 | SP | New Issue: HSBC sells $710,000 contingent income barrier autocalls on Gilead, Amgen, Merck
|
11/10/2021 | SP | New Issue: JPMorgan sells $1.95 million trigger autocallable contingent yield notes on Gilead
|
9/24/2021 | SP | New Issue: JPMorgan prices $8.28 million contingent income autocallables on Gilead Sciences
|
9/14/2021 | SP | New Issue: JPMorgan sells $2.29 million autocallable contingent interest notes on three stocks
|
6/15/2021 | SP | New Issue: JPMorgan prices $11.7 million contingent income autocallables on Gilead
|
6/5/2021 | SP | New Issue: CIBC sells $2.5 million of 6.504% fixed-interest barrier notes on three stocks
|
4/14/2021 | SP | New Issue: UBS prices $201,000 trigger phoenix autocallables linked to Gilead Sciences
|
4/14/2021 | SP | New Issue: UBS prices $247,000 trigger phoenix autocallables linked to Gilead Sciences
|
3/23/2021 | SP | New Issue: GS Finance sells $8.31 million contingent income autocalls on Gilead Sciences
|
1/25/2021 | SP | New Issue: RBC sells $10.06 million 7.25% airbag autocallable yield notes on Gilead
|
1/18/2021 | SP | New Issue: JPMorgan sells $3.63 million autocallable contingent interest notes on Gilead Sciences
|
12/15/2020 | SP | New Issue: UBS prices $161,000 trigger phoenix autocallables linked to Gilead
|
12/8/2020 | SP | New Issue: UBS prices $224,000 trigger phoenix autocallables linked to Gilead Sciences
|
10/28/2020 | SP | New Issue: UBS prices $10 million buffered income autocallables tied to Gilead
|
10/14/2020 | SPSW | Agents sell $237 million to start Q3; single-index pricing improving; leverage still declining
|
10/7/2020 | SP | New Issue: UBS prices $500,000 trigger phoenix autocallables linked to Gilead
|
9/9/2020 | SP | New Issue: JPMorgan sells $815,000 contingent interest autocalls on Gilead Sciences
|
9/2/2020 | SP | New Issue: Goldman prices $1.2 million leveraged basket-linked notes on 20 stocks
|
8/28/2020 | SP | JPMorgan to price contingent interest autocalls tied to Gilead Sciences
|
8/17/2020 | SP | New Issue: Citigroup prices $1.01 million contingent coupon autocallables on three stocks
|
7/16/2020 | SP | New Issue: UBS prices $245,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
7/16/2020 | SP | New Issue: UBS prices $290,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/18/2020 | SP | New Issue: Goldman prices $7.88 million leveraged basket-linked notes on 62 stocks
|
6/4/2020 | SP | New Issue: RBC sells $485,000 contingent coupon barrier autocalls on two stocks
|
5/27/2020 | SP | New Issue: GS Finance sells $2.99 million contingent income autocalls on Gilead Sciences
|
5/26/2020 | SP | New Issue: Goldman prices $2.12 million leveraged buffered basket-linked notes on 26 stocks
|
5/21/2020 | SP | New Issue: RBC prices $491,000 contingent coupon barrier autocalls on Gilead Sciences
|
5/15/2020 | SP | GS Finance plans to price contingent income autocalls on Gilead
|
5/14/2020 | SP | New Issue: Barclays sells $3.22 million phoenix autocallable notes on three stocks
|
5/5/2020 | SP | New Issue: Barclays sells $4.56 million contingent income autocalls on Gilead
|
4/28/2020 | SP | New Issue: UBS prices $1 million trigger autocallable contingent yield notes on Gilead
|
4/28/2020 | SP | New Issue: Goldman prices $910,000 leveraged basket-linked notes on 26 stocks
|
4/28/2020 | SP | New Issue: RBC prices $2.78 million contingent coupon barrier autocalls on Gilead Sciences
|
4/24/2020 | SP | New Issue: Goldman prices $1.73 million leveraged basket-linked notes on 19 stocks
|
4/23/2020 | SP | New Issue: Goldman prices $9.16 million leveraged basket-linked notes on 26 stocks
|
4/20/2020 | SP | UBS to price trigger autocallable contingent yield notes on Gilead Sciences
|
4/15/2020 | SP | New Issue: UBS prices $245,000 trigger phoenix autocallables linked to Gilead
|
4/15/2020 | SP | New Issue: UBS prices $260,000 trigger phoenix autocallables linked to Gilead
|
3/12/2020 | SP | New Issue: JPMorgan prices $698,000 contingent interest autocalls on Gilead Sciences
|
3/6/2020 | SP | New Issue: RBC prices $739,000 contingent coupon barrier autocalls on three stocks
|
3/5/2020 | SP | New Issue: RBC sells $1.94 million contingent coupon barrier autocalls on Gilead, L3Harris
|
2/24/2020 | SP | New Issue: CIBC prices $750,000 capped leveraged notes on basket of 50 stocks
|
2/10/2020 | SP | New Issue: Citi sells $1.18 million callable contingent coupon notes on two ETFs, Gilead Sciences
|
1/23/2020 | SP | New Issue: HSBC prices $14.21 million contingent income autocallables on Gilead Sciences
|
1/16/2020 | SP | New Issue: Scotia sells $6.05 million capped enhanced participation notes on basket of 49 stocks
|
1/10/2020 | SP | New Issue: UBS prices $245,000 trigger phoenix autocallables linked to Gilead
|
1/7/2020 | SP | New Issue: UBS prices $185,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
1/7/2020 | SP | New Issue: JPMorgan sells $1.17 million contingent interest autocalls on pharma stocks
|
12/24/2019 | SP | New Issue: Citigroup prices $4.77 million contingent coupon autocallables on Eli Lilly, Gilead
|
12/20/2019 | SP | New Issue: Citigroup prices $2.07 million contingent coupon autocallables on two stocks
|
12/13/2019 | SP | New Issue: UBS prices $640,000 contingent absolute return autocallable optimization securities linked to Gilead Sciences
|
12/13/2019 | SP | New Issue: UBS prices $1.4 million contingent absolute return autocallable optimization securities linked to Gilead Sciences
|
12/13/2019 | SP | New Issue: UBS prices $260,000 contingent absolute return autocallable optimization securities linked to Gilead Sciences
|
11/18/2019 | SP | New Issue: RBC prices $719,000 contingent coupon barrier notes linked to Biogen, Gilead Sciences
|
11/14/2019 | SP | RBC intends to price contingent coupon barrier autocalls on two stocks
|
10/15/2019 | SP | New Issue: UBS prices $200,000 contingent absolute return autocallable optimization securities linked to Gilead Sciences
|
8/20/2019 | SP | New Issue: RBC sells $135,000 contingent coupon barrier autocalls on three stocks
|
8/7/2019 | SP | New Issue: JPMorgan prices $1.8 million contingent interest autocalls linked to pharma stocks
|
7/30/2019 | SP | New Issue: JPMorgan prices $1.84 million contingent interest autocallables linked to pharma stocks
|
7/25/2019 | SP | New Issue: JPMorgan prices $647,000 contingent interest autocallables linked to Gilead Sciences
|
7/15/2019 | SP | JPMorgan to price contingent interest autocallables on three stocks
|
6/26/2019 | SP | New Issue: CIBC sells $133,000 notes tied to 14 Raymond James Healthcare top picks
|
6/26/2019 | SP | New Issue: CIBC sells $253,000 notes tied to 14 Raymond James Healthcare top picks
|
6/7/2019 | SP | CIBC plans Raymond James Healthcare Top Selections notes on 14 stocks
|
6/7/2019 | SP | CIBC eyes Raymond James Healthcare Top Selections notes on 14 stocks
|
5/30/2019 | SP | New Issue: CIBC sells $370,000 Raymond James Healthcare Top Selections notes on 15 stocks
|
5/30/2019 | SP | New Issue: CIBC sells $1.64 million Raymond James Healthcare Top Selections notes on 15 stocks
|
5/14/2019 | SP | New Issue: UBS prices $642,000 trigger autocallables linked to Gilead Sciences
|
5/10/2019 | SP | New Issue: RBC sells $12.3 million 7% airbag autocallable yield notes on Gilead
|
5/9/2019 | SP | UBS plans to price trigger autocallables linked to Gilead Sciences
|
5/2/2019 | SP | RBC plans to price 7% airbag autocallable yield notes on Gilead Sciences
|
4/11/2019 | SP | New Issue: CIBC sells $3.72 million notes on Raymond James stock selections
|
4/11/2019 | SP | New Issue: CIBC sells $701,000 notes on Raymond James equity securities selections
|
3/20/2019 | SP | New Issue: BofA sells $1.23 million contingent income autocallables on two stocks
|
3/14/2019 | SP | BofA to price contingent income autocallables on Gilead, Marathon
|
3/6/2019 | SP | New Issue: Citigroup sells $500,000 autocallable equity-linked notes on four stocks
|
2/19/2019 | SP | New Issue: RBC prices $1.61 million 11% callable notes on three pharma stocks
|
2/14/2019 | SP | Citigroup plans autocallable equity-linked notes tied to four stocks
|
2/12/2019 | SP | RBC plans to price 11% callable notes linked to three pharma stocks
|
1/9/2019 | SP | New Issue: Credit Suisse sells $500,000 contingent coupon autocallable yield notes on stocks
|
11/27/2018 | SP | New Issue: HSBC sells $2.67 million 9.3% airbag autocallable yield notes on Gilead Sciences
|
11/15/2018 | SP | HSBC eyes 8.1%-9.1% airbag autocallable yield notes on Gilead Sciences
|
10/31/2018 | SP | New Issue: BMO sells $150,000 notes on Raymond James quality yield stock basket
|
10/31/2018 | SP | New Issue: BMO sells $315,000 notes on Raymond James quality yield stock basket
|
10/31/2018 | SP | New Issue: BMO sells $292,000 notes on eight Raymond James biotechnology top picks
|
10/31/2018 | SP | New Issue: BMO sells $390,000 notes on eight Raymond James biotechnology top picks
|
10/31/2018 | SP | New Issue: CIBC sells $120,000 notes on Raymond James top pick healthcare stocks
|
10/31/2018 | SP | New Issue: CIBC sells $400,000 notes on Raymond James top pick healthcare stocks
|
10/26/2018 | SP | New Issue: JPMorgan prices $1.33 million 9.5% contingent interest autocalls on two stocks
|
10/23/2018 | SP | New Issue: JPMorgan prices $500,000 of 10% contingent interest autocalls on stocks
|
10/19/2018 | SP | New Issue: Credit Suisse sells $1.24 million contingent coupon autocallable reverse convertibles on Gilead
|
10/18/2018 | SP | CIBC to price notes on 11 Raymond James top pick healthcare stocks
|
10/18/2018 | SP | CIBC plans notes on 11 Raymond James top pick healthcare stocks
|
10/11/2018 | SP | BMO plans notes due 2020 tied to Raymond James biotech top picks
|
10/11/2018 | SP | BMO to price notes due 2020 tied to Raymond James biotech top picks
|
10/8/2018 | SP | New Issue: BMO sells $1.23 million notes on eight Raymond James Biotechnology Sector top picks
|
10/8/2018 | SP | New Issue: BMO sells $1.02 million notes on eight Raymond James Biotechnology Sector top picks
|
9/26/2018 | SP | New Issue: Barclays prices $714,000 of 15% phoenix autocalls tied to three stocks
|
9/20/2018 | SP | New Issue: Credit Suisse sells $729,000 6.7% autocallable reverse convertibles on Gilead
|
8/27/2018 | SP | New Issue: Morgan Stanley sells $1.02 million 11.24% worst-of autocall RevCons on three stocks
|
8/16/2018 | SP | New Issue: RBC prices $542,000 8.85% contingent coupon autocalls on three stocks
|
8/8/2018 | SP | New Issue: RBC sells $1.4 million contingent coupon barrier autocalls on three stocks
|
8/8/2018 | SP | RBC plans 8.85%-9.85% contingent coupon autocalls tied to three stocks
|
7/31/2018 | SP | New Issue: Credit Suisse sells $1.45 million contingent coupon autocallable reverse convertibles on three stocks
|
7/23/2018 | SP | RBC plans 8.4%-9.6% contingent coupon autocalls tied to three stocks
|
4/19/2018 | SP | New Issue: Barclays sells $1.23 million 10.25% contingent income autocalls tied to Gilead Sciences
|
3/16/2018 | SP | New Issue: GS Finance prices $6.85 million contingent income autocallables on Gilead
|
3/8/2018 | SP | New Issue: Goldman prices $7.79 million 10.25% contingent income autocalls on Gilead
|
3/5/2018 | SP | New Issue: BMO sells $28,000 bullish enhanced notes on Ameriprise IRG Quality Factor stocks
|
3/5/2018 | SP | New Issue: BMO sells $198,000 bullish enhanced notes on Ameriprise IRG Quality Factor stocks
|
3/5/2018 | SP | New Issue: BMO sells $88,000 bullish enhanced notes on Ameriprise IRG Quality Factor stocks
|
3/5/2018 | SP | New Issue: BMO sells $63,000 bullish enhanced notes on Ameriprise IRG Quality Factor stocks
|
3/1/2018 | SP | New Issue: Barclays sells $3.63 million 9.2% contingent income autocalls tied to Gilead
|
2/22/2018 | SP | BMO eyes bullish enhanced notes on Ameriprise Quality Factor stocks
|
2/22/2018 | SP | BMO plans bullish enhanced notes on Ameriprise Quality Factor stocks
|
2/22/2018 | SP | BMO to sell bullish enhanced notes on Ameriprise Quality Factor stocks
|
2/22/2018 | SP | BMO to price bullish enhanced notes on Ameriprise Quality Factor stocks
|
2/13/2018 | SP | New Issue: UBS prices $882,500 trigger phoenix autocallables linked to Gilead Sciences
|
2/9/2018 | SP | New Issue: Citigroup sells $572,000 autocallable equity-linked notes tied to pharma stocks
|
2/9/2018 | SP | New Issue: Citi sells $1.83 million 12% contingent coupon autocalls tied to four stocks
|
2/7/2018 | SP | New Issue: Citi sells $344,000 9% contingent coupon autocalls tied to three stocks
|
2/1/2018 | SP | New Issue: Credit Suisse sells $2.22 million contingent coupon autocallable yield notes on stocks
|
1/22/2018 | SP | Credit Suisse plans 10% contingent coupon autocallables on stocks
|
1/19/2018 | SP | New Issue: UBS prices $140,000 trigger phoenix autocallables linked to Gilead
|
1/19/2018 | SP | New Issue: JPMorgan sells $784,000 contingent interest autocallables on Gilead
|
1/12/2018 | SP | Citi plans 9% contingent coupon autocallables tied to three stocks
|
1/12/2018 | SP | Citi plans 12% contingent coupon autocallables tied to four stocks
|
12/26/2017 | SP | New Issue: Wells Fargo prices $2 million 9% contingent market-linked autocalls tied to stocks
|
12/20/2017 | SP | New Issue: Barclays sells $813,000 two-year phoenix autocallables tied to four stocks
|
12/14/2017 | SP | New Issue: RBC prices $1.83 million 11.68% contingent coupon autocalls linked to stocks
|
12/6/2017 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallables linked to Gilead
|
12/5/2017 | SP | New Issue: RBC prices $500,000 contingent coupon barrier autocallables on Gilead
|
11/29/2017 | SP | New Issue: Morgan Stanley sells $6.79 million contingent income autocallables tied to Gilead
|
11/15/2017 | SP | New Issue: JPMorgan sells $1.99 million contingent income autocallables tied to Gilead
|
11/15/2017 | SPSW | Sales are slow in early part of the month with $231 million; single-stocks volume is up
|
11/13/2017 | SP | Morgan Stanley plans contingent income autocallables linked to Gilead
|
11/13/2017 | SP | New Issue: UBS prices $647,500 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
11/1/2017 | SP | New Issue: HSBC prices $10.94 million contingent income autocallables tied to Gilead
|
10/26/2017 | SP | New Issue: Morgan Stanley sells $3.42 million 5.52% contingent income autocalls on pharma stocks
|
10/24/2017 | SP | HSBC plans 8.6% three-year contingent income autocalls tied to Gilead
|
10/11/2017 | SP | New Issue: Morgan Stanley prices $2.96 million contingent income autocallables on three stocks
|
10/2/2017 | SP | New Issue: Credit Suisse prices $2.79 million contingent coupon autocallables linked to Gilead
|
9/27/2017 | SP | New Issue: Credit Suisse prices $500,000 10% autocallable reverse convertibles linked to pharma stocks
|
9/21/2017 | SP | Credit Suisse plans contingent coupon reverse convertibles on Gilead
|
8/31/2017 | SP | New Issue: Barclays prices $2.16 million phoenix autocallables tied to three stocks
|
8/8/2017 | SP | New Issue: JPMorgan prices $4.27 million contingent income autocallables linked to Gilead
|
8/8/2017 | SP | New Issue: JPMorgan prices $2.46 million contingent income autocallables linked to Gilead
|
7/31/2017 | SP | JPMorgan plans contingent income autocallables tied to Gilead Sciences
|
6/22/2017 | SP | New Issue: Credit Suisse sells $3.44 million contingent coupon autocallable reverse convertibles on Gilead
|
6/6/2017 | SP | New Issue: Barclays sells $2.55 million phoenix autocallable notes on three stocks
|
5/11/2017 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
5/11/2017 | SP | Barclays plans phoenix autocallables due 2020 linked to three stocks
|
4/18/2017 | SP | New Issue: Credit Suisse sells $679,000 autocallable yield notes on pharma stocks
|
4/3/2017 | SP | New Issue: Credit Suisse sells $2.68 million trigger autocallable notes on Gilead
|
3/23/2017 | SP | Credit Suisse plans trigger autocallable notes linked to Gilead
|
3/13/2017 | SP | New Issue: UBS prices $795,000 trigger phoenix autocallables linked to Gilead Sciences
|
3/3/2017 | SP | New Issue: UBS prices $1.49 million phoenix autocallable memory interest notes on Gilead Sciences
|
3/1/2017 | SP | New Issue: UBS prices $105,000 trigger phoenix autocallables linked to Gilead
|
2/24/2017 | SP | Market Commentary: UBS’ phoenix autocallables tied to Gilead Sciences to show various risk-return outcomes
|
2/22/2017 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Gilead Sciences
|
2/22/2017 | SP | UBS plans phoenix autocallable memory interest notes on Gilead Sciences
|
2/14/2017 | SP | New Issue: UBS prices $109,000 trigger phoenix autocallables linked to Gilead
|
2/13/2017 | SP | New Issue: UBS prices $633,500 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
2/6/2017 | SP | New Issue: HSBC sells $10.7 million contingent income autocallables tied to Gilead
|
1/27/2017 | SP | New Issue: JPMorgan prices $1 million contingent interest autocallables tied to pharma stocks
|
1/23/2017 | SP | HSBC plans to price contingent income autocallables tied to Gilead Sciences
|
1/19/2017 | SP | New Issue: UBS prices $110,000 trigger phoenix autocallables linked to Gilead
|
1/19/2017 | SP | New Issue: UBS prices $300,000 trigger phoenix autocallables linked to Gilead
|
1/12/2017 | SP | JPMorgan plans contingent interest autocallables tied to three stocks
|
12/12/2016 | SP | New Issue: Morgan Stanley sells $3.85 million worst-of autocallable RevCons on three stocks
|
11/18/2016 | SP | New Issue: UBS prices $303,000 trigger phoenix autocallables linked to Gilead Sciences
|
11/18/2016 | SP | New Issue: UBS prices $167,000 trigger phoenix autocallables linked to Gilead Sciences
|
11/16/2016 | SP | New Issue: JPMorgan sells $228,000 8% autocallable yield notes linked to Gilead
|
11/15/2016 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
11/8/2016 | SP | JPMorgan plans 8% one-year autocallable yield notes linked to Gilead
|
10/28/2016 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallables linked to Gilead
|
10/24/2016 | SP | New Issue: UBS prices $150,000 return optimization securities on Gilead Sciences
|
10/20/2016 | SP | New Issue: UBS prices $185,000 airbag yield optimization notes on Gilead
|
10/18/2016 | SP | New Issue: GS prices $6.78 million contingent income autocallables linked to Gilead Sciences
|
10/12/2016 | SP | Goldman Sachs plans variable coupon CDs due 2021 linked to 10 stocks
|
10/12/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 linked to 10 stocks
|
10/12/2016 | SP | Goldman Sachs plans variable coupon CDs due 2026 linked to 10 stocks
|
10/12/2016 | SP | Goldman Sachs to price variable coupon CDs due 2023 tied to 10 stocks
|
10/7/2016 | SP | GS Finance plans contingent income autocallables linked to Gilead
|
10/3/2016 | SP | New Issue: JPMorgan sells $560,000 of contingent interest autocallables on Gilead
|
9/23/2016 | SP | JPMorgan plans contingent interest autocallable notes tied to Gilead
|
9/21/2016 | SP | New Issue: Credit Suisse prices $3.32 million contingent coupon autocallables tied to Gilead
|
9/20/2016 | SP | New Issue: HSBC prices $715,000 phoenix quarterly review notes linked to Gilead
|
9/16/2016 | SP | New Issue: HSBC prices $3 million of AMPS linked to basket of 20 common stocks
|
9/13/2016 | SP | HSBC plans phoenix quarterly review notes linked to Gilead Sciences
|
9/13/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 tied to 10 stocks
|
9/13/2016 | SP | Goldman Sachs plans variable coupon CDs due 2026 linked to 10 stocks
|
9/13/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 linked to 10 stocks
|
9/13/2016 | SP | Goldman Sachs plans variable coupon CDs due 2021 linked to 10 stocks
|
9/8/2016 | SP | HSBC plans 15-month AMPS with cap linked to basket of 20 stocks
|
9/7/2016 | SP | Credit Suisse plans contingent coupon autocallable yield notes on Gilead
|
9/6/2016 | SP | New Issue: UBS prices $120,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/2/2016 | SP | New Issue: Credit Suisse sells $2.82 million of 8.25% autocallable reverse convertibles on Gilead
|
9/1/2016 | SP | New Issue: JPMorgan prices $1.95 million contingent interest autocallables linked to Gilead
|
8/26/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Gilead
|
8/23/2016 | SP | New Issue: RBC prices $760,000 contingent coupon barrier autocallables on Gilead
|
8/22/2016 | SP | JPMorgan plans three-month contingent interest autocallables on Gilead
|
8/16/2016 | SP | Credit Suisse plans autocallable reverse convertibles linked to Gilead
|
8/15/2016 | SP | New Issue: TD Bank prices $4.4 million 6.4% autocallable barrier notes linked to Gilead Sciences
|
8/9/2016 | SP | New Issue: Credit Suisse prices $11.39 million trigger autocallables linked to Gilead Sciences
|
8/9/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 linked to 10 stocks
|
8/9/2016 | SP | Goldman Sachs plans variable coupon CDs due 2026 linked to 10 stocks
|
8/9/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 linked to 10 stocks
|
8/9/2016 | SP | Goldman Sachs plans to price variable coupon CDs linked to 10 stocks
|
8/8/2016 | SP | New Issue: JPMorgan prices $600,000 callable contingent interest notes linked to Gilead Sciences
|
8/4/2016 | SP | Credit Suisse to price trigger autocallables linked to Gilead Sciences
|
7/29/2016 | SP | New Issue: UBS prices $128,000 trigger phoenix autocallables linked to Gilead
|
7/29/2016 | SP | New Issue: UBS prices $1 million trigger phoenix autocallables linked to Gilead
|
7/27/2016 | SP | New Issue: UBS prices $436,000 trigger autocallables linked to Gilead Sciences
|
7/26/2016 | SP | New Issue: UBS prices $175,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
7/26/2016 | SP | New Issue: UBS prices $300,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
7/26/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
7/26/2016 | SP | New Issue: UBS prices $99,853 6.31% trigger yield optimization notes linked to Gilead Sciences
|
7/20/2016 | SP | New Issue: UBS prices $110,000 trigger phoenix autocallables linked to Gilead
|
7/19/2016 | SP | New Issue: Barclays prices $1.11 million phoenix autocallables linked to Gilead
|
7/15/2016 | SP | New Issue: JPMorgan prices $540,000 7.5% autocallable yield notes linked to Gilead
|
7/12/2016 | SP | Barclays to price phoenix autocallables linked to Gilead Sciences
|
7/11/2016 | SP | Goldman Sachs plans to price variable coupon CDs linked to 10 stocks
|
7/11/2016 | SP | Goldman Sachs plans variable coupon CDs due 2026 linked to 10 stocks
|
7/11/2016 | SP | Goldman Sachs plans variable coupon CDs due 2023 linked to 10 stocks
|
7/11/2016 | SP | Goldman Sachs plans variable coupon CDs due 2021 linked to 10 stocks
|
7/1/2016 | SP | New Issue: Morgan Stanley prices $2.16 million contingent income autocallables on IBM, Gilead
|
6/21/2016 | SP | JPMorgan to price 7.5%-9.5% autocallable yield notes linked to Gilead
|
6/14/2016 | SP | New Issue: JPMorgan prices $1.63 million 7.5% callable reverse exchangeables linked to Gilead Sciences
|
6/13/2016 | SP | New Issue: Deutsche Bank prices $1.14 million autocallable securities on Gilead
|
6/13/2016 | SP | Goldman Sachs Bank to price variable-coupon CDs due 2021 on 10 stocks
|
6/13/2016 | SP | Goldman Sachs Bank plans variable-coupon CDs due 2023 on 10 stocks
|
6/13/2016 | SP | Goldman Sachs Bank to price variable-coupon CDs due 2026 on 10 stocks
|
6/13/2016 | SP | Goldman Sachs Bank to price variable-coupon CDs due 2023 on 10 stocks
|
6/3/2016 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallables linked to Gilead
|
6/1/2016 | SP | JPMorgan plans 7.5%-9.5% callable reverse exchangeables tied to Gilead
|
5/23/2016 | SP | New Issue: Credit Suisse prices $1.82 million contingent coupon autocallables on pharma stocks
|
5/18/2016 | SP | Credit Suisse plans contingent coupon autocallable yield notes linked to three stocks
|
5/17/2016 | SP | New Issue: JPMorgan prices $676,000 contingent interest autocallables linked to pharma stocks
|
5/11/2016 | SP | New Issue: JPMorgan prices $1.31 million autocallable contingent interest notes tied to Gilead
|
5/10/2016 | SP | New Issue: JPMorgan prices $8.12 million trigger autocallables linked to Gilead Sciences
|
5/9/2016 | SP | Goldman Sachs plans variable-coupon CDs due 2023 tied to stock basket
|
5/9/2016 | SP | Goldman Sachs Bank to price variable-coupon CDs due 2023 on 10 stocks
|
5/9/2016 | SP | Goldman Sachs plans variable-coupon CDs due 2023 linked to 10 stocks
|
5/9/2016 | SP | Goldman Sachs Bank plans variable-coupon CDs due 2020 on 10 stocks
|
5/9/2016 | SP | Goldman Sachs Bank plans variable-coupon CDs due 2026 on 10 stocks
|
5/9/2016 | SP | Goldman Sachs Bank plans variable-coupon CDs due 2021 on 10 stocks
|
5/5/2016 | SP | JPMorgan plans autocallable contingent interest notes on three stocks
|
5/5/2016 | SP | JPMorgan plans 9% trigger autocallable contingent yield notes on Gilead
|
5/3/2016 | SP | JPMorgan plans autocallable contingent interest notes linked to Gilead
|
4/19/2016 | SP | New Issue: GS Finance sells $2.83 million contingent income autocallables linked to Gilead
|
4/13/2016 | SP | New Issue: UBS prices $379,624 4.97% trigger yield optimization notes linked to Gilead
|
4/8/2016 | SP | GS Finance plans one-year contingent income autocallables on Gilead
|
3/24/2016 | SP | New Issue: Wells Fargo prices $5.23 million of 0.125% notes tied to pharma stocks
|
3/22/2016 | SP | Wells Fargo to price 0.125% notes linked to four pharma stocks
|
3/3/2016 | SP | New Issue: HSBC prices $8.58 million income notes linked to basket of 20 stocks
|
2/29/2016 | SP | New Issue: JPMorgan prices $2.03 million buffered return optimization notes linked to 10 stocks
|
2/18/2016 | SP | New Issue: Credit Suisse sells $1.01 million contingent coupon autocallable notes on Gilead
|
2/12/2016 | SP | HSBC plans to price income notes linked to basket of 20 common stocks
|
2/9/2016 | SP | Credit Suisse plans contingent coupon autocallables linked to Gilead
|
2/2/2016 | SP | JPMorgan to price callable reverse exchangeables linked to Gilead
|
2/2/2016 | SP | UBS plans return optimization notes due 2017 with cap tied to stocks
|
12/3/2015 | SP | New Issue: Credit Suisse prices $8.8 million trigger phoenix autocallables linked to Gilead Sciences
|
12/1/2015 | SP | New Issue: Deutsche Bank prices $5.25 million of securities due 2016 tied to Gilead
|
11/23/2015 | SP | Credit Suisse to price trigger phoenix autocallables linked to Gilead
|
10/28/2015 | SP | New Issue: Citigroup prices $1.25 million contingent coupon autocallables linked to Gilead Sciences
|
10/23/2015 | SP | New Issue: RBC prices $2.7 million bullish barrier enhanced notes on five stocks
|
10/20/2015 | SP | New Issue: RBC prices $410,000 bullish barrier enhanced notes linked to five stocks
|
10/19/2015 | SP | RBC plans 0% bullish barrier enhanced notes on basket of five stocks
|
10/15/2015 | SP | RBC plans bullish barrier enhanced return notes on five stocks
|
10/14/2015 | SP | New Issue: JPMorgan prices $503,000 autocallable reverse exchangeables linked to Gilead Sciences
|
10/8/2015 | SP | Citigroup plans contingent coupon autocallables on Gilead Sciences
|
9/30/2015 | SP | JPMorgan plans autocallable reverse exchangeables linked to Gilead
|
9/17/2015 | SP | New Issue: JPMorgan prices $1.21 million autocallable reverse exchangeables linked to Gilead Sciences
|
9/10/2015 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/8/2015 | SP | JPMorgan plans 8%-10% autocallable reverse exchangeables on Gilead
|
9/4/2015 | SP | New Issue: HSBC prices $3.17 million contingent income barrier autocallables linked to Gilead Sciences
|
9/3/2015 | SP | New Issue: JPMorgan prices $1.06 million autocallable reverse exchangeables linked to Gilead Sciences
|
9/1/2015 | SP | New Issue: JPMorgan prices $10.75 million 7% airbag autocallables linked to Gilead
|
8/31/2015 | SP | HSBC plans contingent income barrier autocallables tied to Gilead
|
8/25/2015 | SP | JPMorgan plans 6%-8.5% airbag autocallable notes linked to Gilead
|
8/21/2015 | SP | JPMorgan plans 8%-10% autocallable reverse exchangeables on Gilead
|
8/19/2015 | SP | New Issue: JPMorgan sells $4.4 million trigger phoenix autocallables on Gilead
|
8/17/2015 | SP | New Issue: UBS prices $110,000 contingent absolute return autocallable optimization securities linked to Gilead Sciences
|
8/14/2015 | SP | New Issue: UBS prices $166,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
8/11/2015 | SP | JPMorgan plans to price trigger phoenix autocallables tied to Gilead
|
8/6/2015 | SP | New Issue: UBS prices $160,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
8/5/2015 | SP | New Issue: Morgan Stanley prices $6.5 million contingent income autocallables linked to Gilead
|
7/28/2015 | SP | New Issue: JPMorgan prices $1.25 million autocallable contingent interest notes linked to Gilead Sciences
|
7/24/2015 | SP | New Issue: JPMorgan prices $10.8 million autocallable reverse exchangeables linked to Celgene, Gilead
|
7/24/2015 | SP | Morgan Stanley plans contingent income autocallables on Gilead Sciences
|
7/22/2015 | SP | JPMorgan plans contingent interest autocallable notes linked to Gilead
|
7/21/2015 | SP | New Issue: Barclays sells $11.09 million contingent income autocallables on Gilead
|
7/14/2015 | SP | JPMorgan plans autocallable reverse exchangeables on Celgene, Gilead
|
7/9/2015 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
7/9/2015 | SP | Barclays plans contingent income autocallables tied to Gilead Sciences
|
7/8/2015 | SP | New Issue: Credit Suisse prices $731,000 7.5% autocallable reverse convertibles tied to Gilead
|
7/2/2015 | SP | New Issue: Deutsche prices $4.13 million contingent absolute return autocallables on Gilead
|
6/25/2015 | SP | New Issue: UBS prices $343,000 trigger autocallables linked to Gilead Sciences
|
6/25/2015 | SP | New Issue: UBS prices $410,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/24/2015 | SP | Deutsche Bank plans contingent absolute return notes linked to Gilead
|
6/23/2015 | SP | New Issue: UBS prices $155,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/22/2015 | SP | Credit Suisse plans 7%-9% reverse convertible autocallables on Gilead
|
6/16/2015 | SP | New Issue: UBS prices $2.94 million contingent income autocallables tied to Gilead
|
6/4/2015 | SP | UBS plans one-year contingent income autocallables linked to Gilead
|
6/2/2015 | SP | New Issue: JPMorgan prices $1.53 million autocallable contingent interest notes linked to Gilead Sciences
|
6/2/2015 | SP | New Issue: JPMorgan prices $3.27 million autocallable contingent interest notes linked to stocks
|
6/1/2015 | SP | New Issue: Credit Suisse prices $2.26 million 7.5% autocallable reverse convertibles on Gilead
|
5/29/2015 | SP | New Issue: RBC prices $1 million trigger phoenix autocallable notes linked to Celgene, Gilead
|
5/27/2015 | SP | JPMorgan plans autocallable contingent interest notes linked to Gilead
|
5/20/2015 | SP | JPMorgan plans contingent interest autocallable notes linked to Gilead
|
5/19/2015 | SP | New Issue: JPMorgan prices $464,000 autocallable reverse exchangeables on Gilead
|
5/15/2015 | SP | JPMorgan plans contingent income autocallables tied to Gilead Sciences
|
5/13/2015 | SPSW | May kicks off on good note with $446 million priced in 112 offerings; agents sell repeat deals
|
5/8/2015 | SP | New Issue: UBS prices $503,650 return optimization securities on Gilead Sciences
|
5/5/2015 | SP | Credit Suisse plans autocallable reverse convertibles linked to Gilead
|
5/5/2015 | SP | JPMorgan plans autocallable reverse exchangeable notes tied to Gilead
|
4/30/2015 | SP | Market Commentary: Citi prices $1.27 million autocallables tied to stocks with eye-catching 31% contingent coupon
|
4/29/2015 | SP | New Issue: JPMorgan prices $2.07 million autocallable contingent interest notes linked to stocks
|
4/28/2015 | SP | New Issue: Morgan Stanley prices $6.48 million contingent income autocallables linked to Gilead
|
4/17/2015 | SP | New Issue: JPMorgan prices $389,000 autocallable 7% reverse exchangeables linked to Gilead
|
4/16/2015 | SP | Morgan Stanley plans contingent income autocallables on Gilead Sciences
|
4/14/2015 | SP | New Issue: UBS prices $129,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
4/14/2015 | SP | New Issue: JPMorgan prices $3.68 million autocallable contingent interest notes linked to Gilead Sciences
|
4/14/2015 | SP | New Issue: JPMorgan prices $7.25 million 9.75% autocallable reverse exchangeables on two stocks
|
4/8/2015 | SP | New Issue: UBS prices $379,805 4.37% trigger yield optimization notes linked to Gilead Sciences
|
4/8/2015 | SP | JPMorgan plans 7%-9% autocallable reverse exchangeable notes on Gilead
|
4/7/2015 | SP | JPMorgan plans contingent interest autocallables on Gilead Sciences
|
4/7/2015 | SP | JPMorgan plans autocallable reverse exchangeables tied to two stocks
|
4/2/2015 | SP | New Issue: JPMorgan prices $2.35 million autocallable contingent interest notes linked to stocks
|
3/31/2015 | SP | New Issue: JPMorgan prices $3.17 million trigger phoenix autocallables linked to Gilead
|
3/24/2015 | SP | JPMorgan plans trigger phoenix autocallables linked to Gilead
|
3/11/2015 | SP | New Issue: UBS prices $5.83 million contingent income autocallables tied to Gilead
|
3/6/2015 | SP | New Issue: UBS prices $113,000 trigger autocallables linked to Gilead Sciences
|
3/4/2015 | SP | New Issue: Citigroup prices $1 million autocallable contingent coupon securities on stocks
|
3/3/2015 | SP | New Issue: JPMorgan prices $1.7 million autocallable reverse exchangeable notes linked to Gilead
|
3/2/2015 | SP | UBS plans to price contingent income autocallables on Gilead
|
2/26/2015 | SP | New Issue: Morgan Stanley prices $2.62 million contingent income autocallable securities on Gilead
|
2/24/2015 | SP | JPMorgan plans autocallable reverse exchangeable notes on Gilead
|
2/20/2015 | SP | New Issue: JPMorgan prices $983,000 8% autocallable reverse convertibles linked to Gilead
|
2/13/2015 | SP | New Issue: UBS prices $205,000 trigger return optimization securities linked to Gilead Sciences
|
2/12/2015 | SP | New Issue: UBS prices $532,000 trigger return optimization securities linked to Gilead Sciences
|
2/10/2015 | SP | New Issue: UBS prices $468,000 trigger return optimization securities linked to Gilead Sciences
|
2/10/2015 | SP | JPMorgan plans autocallable reverse exchangeable notes on Gilead
|
2/9/2015 | SP | New Issue: UBS prices $129,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
2/5/2015 | SP | New Issue: UBS prices $156,942 7.68% trigger yield optimization notes linked to Gilead Sciences
|
2/4/2015 | SP | New Issue: UBS prices $100,000 contingent absolute return autocallable optimization securities linked to Gilead Sciences
|
2/4/2015 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
2/4/2015 | SP | New Issue: UBS prices $99,906 8.03% trigger yield optimization notes linked to Gilead Sciences
|
2/4/2015 | SP | New Issue: UBS prices $150,000 trigger return optimization securities linked to Gilead Sciences
|
2/3/2015 | SP | New Issue: UBS prices $108,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
2/2/2015 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
1/29/2015 | SP | New Issue: Deutsche Bank prices $2.13 million trigger phoenix autocallables linked to Gilead Sciences
|
1/21/2015 | SP | New Issue: Credit Suisse prices $5.16 million trigger phoenix autocallables linked to Gilead Sciences
|
1/21/2015 | SP | New Issue: Credit Suisse prices $1.89 million contingent coupon autocallables on Gilead Sciences
|
1/13/2015 | SP | Credit Suisse plans contingent coupon autocallables linked to Gilead
|
1/13/2015 | SP | New Issue: RBC prices $7.07 million phoenix autocallable notes on Gilead Sciences
|
1/12/2015 | SP | Credit Suisse plans trigger phoenix autocallables on Gilead Sciences
|
1/8/2015 | SP | RBC to price phoenix autocallable notes linked to Gilead Sciences
|
12/30/2014 | SP | New Issue: Barclays prices $1.5 million autocallable notes linked to two stocks
|
12/29/2014 | SP | New Issue: JPMorgan prices $3.95 million 8% reverse exchangeables linked to Gilead Sciences
|
12/24/2014 | SP | New Issue: Citigroup prices $2.18 million contingent coupon autocallables on Gilead Sciences
|
12/23/2014 | SP | New Issue: UBS prices $117,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
12/22/2014 | SP | New Issue: UBS prices $4.36 million contingent absolute return autocallables tied to Gilead
|
12/18/2014 | SP | JPMorgan plans 8% single observation reverse exchangeables on Gilead
|
12/17/2014 | SP | New Issue: RBC prices $6.23 million contingent absolute return autocallables linked to Gilead
|
12/15/2014 | SP | UBS plans contingent absolute return autocallables on Gilead Sciences
|
12/10/2014 | SP | RBC plans contingent absolute return autocallables tied to Gilead
|
12/10/2014 | SP | Citigroup to price contingent coupon autocallables on Gilead Sciences
|
12/9/2014 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
12/5/2014 | SP | New Issue: UBS prices $220,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
12/1/2014 | SP | New Issue: JPMorgan prices $3.73 million auto callable contingent interest notes linked to Gilead Sciences
|
12/1/2014 | SP | New Issue: RBC prices $2.12 million buffered optimization notes tied to health care stocks
|
12/1/2014 | SP | New Issue: Barclays prices $13.78 million trigger phoenix autocallables on Gilead Sciences
|
11/26/2014 | SP | New Issue: Barclays prices $26.46 million 14-month Accelerated Return Notes tied to biotech stocks
|
11/25/2014 | SP | JPMorgan plans contingent interest autocallables on Gilead Sciences
|
11/24/2014 | SP | New Issue: Morgan Stanley prices $2.69 million contingent income autocallable securities on Gilead
|
11/24/2014 | SP | New Issue: Credit Suisse prices $2.93 million of 9.25% autocallable reverse convertibles on Gilead
|
11/24/2014 | SP | New Issue: UBS prices $208,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
11/24/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
11/21/2014 | SP | New Issue: CIBC prices $2.7 million 8.05% autocallable securities tied to Gilead
|
11/20/2014 | SP | CIBC plans 8.05% autocallable equity-linked securities tied to Gilead
|
11/20/2014 | SP | Barclays plans trigger phoenix autocallables linked to Gilead Sciences
|
11/19/2014 | SP | New Issue: UBS prices $149,928 7.37% trigger yield optimization notes linked to Gilead Sciences
|
11/19/2014 | SP | Market Commentary: HSBC’s $39.75 million 10% STEP Income tied to Gilead offer bullish bet on stock, no barrier
|
11/19/2014 | SPSW | November shows weakness with volume down by a third, but sources say month is not over yet
|
11/19/2014 | SP | New Issue: UBS prices $100,000 airbag return optimization securities linked to Gilead Sciences
|
11/18/2014 | SP | New Issue: HSBC prices $39.75 million 10% STEP Income Securities on Gilead Sciences
|
11/18/2014 | SP | Barclays plans 14-month Accelerated Return Notes tied to biotech stocks
|
11/13/2014 | SP | Morgan Stanley plans contingent income autocallables tied to Gilead
|
11/13/2014 | SP | New Issue: RBC prices $14.85 million 8.24% airbag autocallables linked to Gilead
|
11/12/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
11/7/2014 | SP | Credit Suisse plans autocallable reverse convertibles tied to Gilead
|
11/5/2014 | SP | HSBC to price 10% STEP Income Securities linked to Gilead Sciences
|
11/5/2014 | SP | RBC to price 6.1%-8.1% airbag autocallables linked to Gilead Sciences
|
11/3/2014 | SP | New Issue: UBS prices $185,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/31/2014 | SP | HSBC to price 10% autocallable yield notes linked to three stocks
|
10/31/2014 | SP | New Issue: UBS prices $375,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/30/2014 | SP | New Issue: UBS prices $170,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/30/2014 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/29/2014 | SP | New Issue: UBS prices $195,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/28/2014 | SP | New Issue: UBS prices $215,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/17/2014 | SP | New Issue: UBS prices $233,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/16/2014 | SP | New Issue: UBS prices $253,500 contingent absolute return autocallable optimization securities linked to Gilead Sciences
|
10/15/2014 | SP | New Issue: Barclays prices $8.58 million contingent income autocallables on Gilead
|
10/10/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/10/2014 | SP | New Issue: UBS prices $276,500 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/7/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/7/2014 | SP | Barclays plans contingent income autocallable notes linked to Gilead
|
10/3/2014 | SP | New Issue: UBS prices $252,000 contingent absolute return autocallables linked to Gilead
|
10/3/2014 | SP | New Issue: UBS prices $120,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/3/2014 | SP | New Issue: UBS prices $124,521 8.33% trigger yield optimization notes linked to Gilead Sciences
|
10/1/2014 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/30/2014 | SP | New Issue: UBS prices $4.98 million contingent absolute return autocallables linked to Gilead Sciences
|
9/30/2014 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/24/2014 | SP | New Issue: UBS prices $310,000 contingent absolute return autocallables linked to Gilead Sciences
|
9/24/2014 | SP | New Issue: UBS prices $169,000 trigger autocallables linked to Gilead Sciences
|
9/22/2014 | SP | UBS plans contingent absolute return autocallables linked to Gilead
|
9/19/2014 | SP | New Issue: HSBC prices $1.1 million autocallable contingent interest barrier notes on Gilead Sciences
|
9/18/2014 | SP | New Issue: UBS prices $365,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/17/2014 | SP | New Issue: JPMorgan prices $7.77 million contingent absolute return autocallables tied to Gilead
|
9/16/2014 | SP | New Issue: UBS prices $167,040 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/12/2014 | SP | New Issue: UBS prices $475,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/12/2014 | SP | New Issue: UBS prices $500,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/12/2014 | SP | New Issue: Morgan Stanley prices $1.41 million contingent income autocallables linked to Gilead Sciences
|
9/11/2014 | SP | New Issue: UBS prices $118,080 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/10/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/9/2014 | SP | JPMorgan plans contingent absolute return autocallables on Gilead
|
9/9/2014 | SP | New Issue: JPMorgan prices $1.39 million auto callable contingent interest notes linked to Gilead Sciences
|
9/9/2014 | SP | Morgan Stanley plans contingent income autocallables on Gilead Sciences
|
9/5/2014 | SP | New Issue: UBS prices $140,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/5/2014 | SP | New Issue: UBS prices $99,881 5.06% trigger yield optimization notes linked to Gilead Sciences
|
9/4/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/4/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/4/2014 | SP | JPMorgan plans autocallable contingent interest notes on Gilead
|
9/2/2014 | SP | New Issue: UBS prices $580,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
8/28/2014 | SP | New Issue: JPMorgan sells $1.93 million 8.25% autocall reverse exchangeables on Gilead
|
8/28/2014 | SP | New Issue: JPMorgan sells $1.93 million 8.25% autocall reverse exchangeables on Gilead
|
8/27/2014 | SP | New Issue: Citigroup sells $3.67 million contingent coupon autocallables on Gilead
|
8/20/2014 | SP | New Issue: UBS prices $1 million trigger autocallables linked to Gilead Sciences
|
8/19/2014 | SP | New Issue: JPMorgan prices $1.38 million contingent interest autocallables linked to Gilead
|
8/15/2014 | SP | New Issue: UBS prices $195,900 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
8/14/2014 | SP | JPMorgan plans 8%-10% autocallable reverse exchangeables tied to Gilead
|
8/12/2014 | SP | New Issue: RBC prices $1.94 million phoenix autocallable notes on Gilead Sciences
|
8/12/2014 | SP | JPMorgan plans autocallable contingent interest notes on Gilead
|
8/5/2014 | SP | RBC plans to price phoenix autocallables linked to Gilead Sciences
|
8/4/2014 | SP | Citigroup plans contingent coupon autocallables tied to Gilead Sciences
|
7/31/2014 | SP | New Issue: UBS prices $118,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
7/24/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
7/15/2014 | SP | New Issue: UBS prices $6.48 million airbag phoenix autocallable notes linked to Gilead Sciences
|
7/15/2014 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
7/9/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
7/9/2014 | SP | JPMorgan plans to price return notes linked to basket of 16 stocks
|
7/8/2014 | SP | UBS plans airbag phoenix autocallable notes linked to Gilead Sciences
|
7/8/2014 | SP | New Issue: Morgan Stanley prices $3.53 million contingent income auto-callable securities linked to Gilead Sciences
|
6/30/2014 | SP | New Issue: UBS prices $2.49 million contingent absolute return autocallables linked to Gilead
|
6/27/2014 | SP | Morgan Stanley plans contingent income autocallables linked to Gilead
|
6/25/2014 | SP | UBS plans contingent absolute return autocallables linked to Gilead
|
6/24/2014 | SP | New Issue: UBS prices $605,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/24/2014 | SP | New Issue: UBS prices $259,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/24/2014 | SP | New Issue: UBS prices $330,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/20/2014 | SP | JPMorgan plans capped contingent buffered notes on Gilead Sciences
|
6/17/2014 | SP | New Issue: UBS prices $170,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/16/2014 | SP | New Issue: UBS prices $140,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/9/2014 | SP | New Issue: UBS prices $463,000 trigger autocallables linked to Gilead Sciences
|
5/30/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
5/22/2014 | SP | New Issue: Credit Suisse prices $2.03 million 8% autocallable reverse convertibles on Gilead
|
5/16/2014 | SP | Correction: Cusip for Credit Suisse's RevCons on Gilead is 22547QN85
|
5/13/2014 | SP | Credit Suisse plans autocallable reverse convertibles tied to Gilead
|
5/13/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
5/7/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
4/30/2014 | SP | New Issue: RBC prices $2.86 million 7.6% reverse convertibles linked to Gilead, eBay
|
4/28/2014 | SP | New Issue: UBS prices $170,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
4/25/2014 | SP | New Issue: UBS prices $1 million trigger autocallables linked to Gilead Sciences
|
4/23/2014 | SP | Unrelenting interest in equity helps volume grow by 15.5% to $12.61 billion for year to date
|
4/21/2014 | SP | New Issue: Barclays prices $1.77 million phoenix autocallable notes tied to Gilead
|
4/17/2014 | SP | New Issue: UBS prices $121,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
4/16/2014 | SP | Barclays plans to price phoenix autocallable notes linked to Gilead
|
4/16/2014 | SP | New Issue: Barclays prices $19.72 million 10% Yeelds linked to Gilead Sciences
|
4/16/2014 | SP | New Issue: Barclays prices $15.54 million 3% Yeelds linked to Gilead Sciences
|
4/15/2014 | SP | New Issue: JPMorgan prices $2.06 million autocallable contingent interest notes on Gilead Sciences
|
4/14/2014 | SP | New Issue: UBS prices $333,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
4/11/2014 | SP | New Issue: UBS prices $374,852 4.8% trigger yield optimization notes linked to Gilead Sciences
|
4/9/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
4/8/2014 | SP | JPMorgan to price autocallable contingent interest notes on Gilead
|
4/3/2014 | SP | New Issue: UBS prices $353,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
4/2/2014 | SP | New Issue: JPMorgan prices $5.07 million autocallable contingent interest notes on Gilead Sciences
|
4/2/2014 | SP | New Issue: RBC prices $1 million 7.5% reverse convertibles linked to Gilead Sciences
|
4/1/2014 | SP | New Issue: Credit Suisse prices $2.02 million 8.4% autocallable reverse convertibles on Gilead
|
4/1/2014 | SP | New Issue: JPMorgan sells $10.59 million contingent income autocallables on Gilead
|
4/1/2014 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
3/31/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
3/28/2014 | SP | Market Commentary: JPMorgan's reverse exchangeables linked to Gilead show below-average value due to margins
|
3/26/2014 | SP | JPMorgan to price 9.5%-11.5% reverse exchangeables linked to Gilead
|
3/25/2014 | SP | JPMorgan plans autocallable contingent interest notes linked to Gilead
|
3/25/2014 | SP | New Issue: JPMorgan prices $7.52 million contingent absolute return autocallables on Gilead
|
3/25/2014 | SP | New Issue: JPMorgan prices $5.39 million autocallable contingent interest notes on Gilead Sciences
|
3/24/2014 | SP | New Issue: UBS prices $130,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
3/21/2014 | SP | JPMorgan plans contingent income autocallables tied to Gilead Sciences
|
3/19/2014 | SP | JPMorgan plans contingent absolute return autocallables tied to Gilead
|
3/18/2014 | SP | New Issue: UBS prices $566,500 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
3/18/2014 | SP | New Issue: UBS prices $577,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
3/18/2014 | SP | Credit Suisse plans 8.25% autocallable reverse convertibles on Gilead
|
3/18/2014 | SP | JPMorgan plans autocallable contingent interest notes linked to Gilead
|
3/18/2014 | SP | New Issue: Barclays prices $4.03 million phoenix autocallables on Gilead Sciences
|
3/18/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
3/17/2014 | SP | New Issue: UBS prices $99,971 4.88% trigger yield optimization notes linked to Gilead Sciences
|
3/14/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
3/13/2014 | SP | Barclays plans phoenix autocallable notes linked to Gilead Sciences
|
3/12/2014 | SP | New Issue: UBS prices $305,000 contingent absolute return autocallables linked to Gilead Sciences
|
3/11/2014 | SP | New Issue: JPMorgan prices $2.36 million autocallable contingent interest notes tied to Gilead
|
3/4/2014 | SP | JPMorgan plans autocallable contingent interest notes linked to Gilead
|
3/4/2014 | SP | New Issue: Barclays prices $5.44 million phoenix autocallables linked to Gilead
|
2/26/2014 | SP | Barclays plans phoenix autocallable notes linked to Gilead Sciences
|
2/26/2014 | SP | New Issue: JPMorgan prices $3.24 million airbag phoenix autocallables on Gilead Sciences
|
2/25/2014 | SP | New Issue: UBS prices $109,806 8.61% trigger yield optimization notes linked to Gilead Sciences
|
2/20/2014 | SP | New Issue: UBS prices $579,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
2/19/2014 | SP | JPMorgan plans airbag phoenix autocallables linked to Gilead Sciences
|
2/5/2014 | SP | New Issue: Credit Suisse prices $1.09 million 8.5% autocallable reverse convertibles linked to Gilead
|
1/31/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
1/27/2014 | SP | New Issue: UBS prices $174,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
1/24/2014 | SP | Credit Suisse plans 8% autocallable reverse convertibles on Gilead
|
1/22/2014 | SP | New Issue: RBC prices $2.12 million trigger phoenix autocallable securities tied to Gilead Sciences
|
1/22/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
1/17/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
1/16/2014 | SP | New Issue: UBS prices $525,000 trigger autocallables linked to Gilead Sciences
|
1/14/2014 | SP | New Issue: UBS prices $15.01 million 8.6% airbag autocallables linked to Gilead Sciences
|
1/9/2014 | SP | New Issue: UBS prices $336,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
1/8/2014 | SP | New Issue: UBS prices $335,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
1/2/2014 | SP | UBS to price 6.6%-8.6% airbag autocallables linked to Gilead Sciences
|
12/18/2013 | SP | New Issue: UBS prices $254,547 9.34% trigger yield optimization notes linked to Gilead Sciences
|
12/17/2013 | SP | New Issue: Credit Suisse prices $1.56 million 9% autocallable reverse convertibles on Gilead
|
12/17/2013 | SP | New Issue: Barclays prices $744,000 phoenix autocallables tied to Gilead Sciences
|
12/16/2013 | SP | New Issue: UBS prices $197,976 8.33% trigger yield optimization notes linked to Gilead Sciences
|
12/16/2013 | SP | New Issue: UBS prices $680,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
12/13/2013 | SP | New Issue: JPMorgan prices $1 million autocallable contingent interest notes linked to Gilead Sciences
|
12/10/2013 | SP | New Issue: Deutsche Bank prices $1.43 million phoenix autocallables tied to Gilead
|
12/10/2013 | SP | New Issue: UBS prices $524,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
12/10/2013 | SP | Barclays plans phoenix autocallable notes linked to Gilead Sciences
|
12/10/2013 | SP | New Issue: Credit Suisse prices $20.06 million 12% equity-linked notes on Gilead
|
12/9/2013 | SP | Credit Suisse plans 9% autocallable reverse convertibles on Gilead
|
12/4/2013 | SP | New Issue: Credit Suisse prices $450,000 contingent coupon autocallables linked to five stocks
|
12/4/2013 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
12/4/2013 | SP | Deutsche Bank plans phoenix autocallable securities on Gilead Sciences
|
12/3/2013 | SP | New Issue: Barclays prices $1.5 million phoenix autocallables on Gilead Sciences
|
11/26/2013 | SP | New Issue: JPMorgan prices $1.05 million autocallable contingent interest notes linked to Gilead Sciences
|
11/20/2013 | SP | New Issue: Citigroup prices $5.31 million 7.67% airbag autocallables linked to Gilead Sciences
|
11/19/2013 | SP | New Issue: JPMorgan prices $3.2 million contingent interest autocallables on Gilead Sciences
|
11/19/2013 | SP | JPMorgan plans autocallable contingent interest notes tied to Gilead
|
11/13/2013 | SP | Citigroup to price 6%-7.7% airbag autocallables linked to Gilead
|
11/13/2013 | SP | New Issue: UBS prices $564,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
11/12/2013 | SP | JPMorgan plans autocallable contingent interest notes tied to Gilead
|
10/30/2013 | SP | New Issue: Credit Suisse sells $722,000 7% autocallable reverse convertible notes on Gilead Sciences
|
10/17/2013 | SP | Credit Suisse plans 7% one-year autocallable reverse convertibles linked to Gilead Sciences
|
10/11/2013 | SP | New Issue: UBS prices $127,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
10/8/2013 | SP | New Issue: Citigroup prices $4.93 million 7.75% airbag autocallable yield notes tied to Gilead Sciences
|
10/2/2013 | SP | Citigroup plans 6%-7.6% airbag autocallables linked to Gilead Sciences
|
9/25/2013 | SP | New Issue: UBS prices $311,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/20/2013 | SP | New Issue: UBS prices $185,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
9/17/2013 | SP | New Issue: UBS prices $110,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
8/28/2013 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
8/2/2013 | SP | New Issue: UBS prices $162,720 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
7/23/2013 | SP | New Issue: UBS prices $129,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/25/2013 | SP | New Issue: UBS prices $205,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/12/2013 | SP | Deutsche Bank plans trigger phoenix autocallables on Gilead Sciences
|
6/12/2013 | SP | New Issue: UBS prices $99,986 7.43% trigger yield optimization notes linked to Gilead Sciences
|
6/11/2013 | SP | New Issue: UBS prices $306,000 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
6/11/2013 | SP | New Issue: UBS prices $221,000 trigger autocallables linked to Gilead Sciences
|
6/4/2013 | SP | New Issue: UBS prices $102,130 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
5/8/2013 | SP | New Issue: UBS prices $109,500 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
5/8/2013 | SP | Bid for unprotected leveraged notes, autocallables goes on as equity markets set new highs
|
5/3/2013 | SP | New Issue: Credit Suisse prices $37.95 million 8% equity-linked notes linked to Gilead Sciences
|
4/8/2013 | SP | New Issue: UBS prices $123,800 trigger phoenix autocallable optimization securities linked to Gilead Sciences
|
3/12/2013 | SP | New Issue: UBS prices $906,500 trigger phoenix autocallables on Gilead Sciences
|
3/5/2013 | SP | UBS plans trigger phoenix autocallable securities on Gilead Sciences
|
5/31/2012 | SP | Bank of Montreal plans 9% reverse exchangeables on Gilead Sciences
|
4/27/2012 | SP | New Issue: Bank of Montreal prices $555,000 reverse exchangeable notes linked to Gilead Sciences
|
4/17/2012 | SP | Bank of Montreal plans 11% reverse exchangeables on Gilead Sciences
|
3/20/2012 | SP | New Issue: Deutsche Bank prices $940,000 7.5% airbag notes tied to Gilead Sciences
|
3/14/2012 | SP | Deutsche Bank plans 5.85%-7.85% airbag notes linked to Gilead Sciences
|
3/13/2012 | SP | New Issue: UBS prices $2.97 million trigger phoenix autocallables linked to Gilead
|
3/6/2012 | SP | UBS to price trigger phoenix autocallables linked to Gilead Sciences
|
2/29/2012 | SP | New Issue: RBC prices $996,000 11.25% reverse convertibles linked to Gilead Sciences
|
2/22/2012 | SP | New Issue: UBS prices $166,000 trigger autocallables linked to Gilead Sciences
|
2/22/2012 | SP | New Issue: UBS prices $179,000 trigger autocallables linked to Gilead Sciences
|
2/16/2012 | SP | RBC to price 11.25% reverse convertibles linked to Gilead Sciences
|
11/29/2010 | SP | New Issue: RBC prices $1.5 million 11.3% reverse convertibles linked to Gilead Sciences
|
2/1/2010 | SP | New Issue: Bank of America sells $28.6 million 10% reverse mandatory exchangeables on Gilead Sciences
|
1/21/2009 | SP | RBC to price 13% RevCons linked to Gilead
|
12/22/2006 | SP | New Issue: Barclays sells $1 million 8.5% reverse convertibles linked to Gilead
|
12/20/2006 | SP | New Issue: JPMorgan prices $1 million of 8.75% reverse exchangeables linked to Gilead
|
12/6/2006 | SP | Barclays to price 8.5% reverse convertibles linked to Gilead Sciences
|
12/4/2006 | SP | Barclays to price 8.5% reverse convertibles linked to Gilead
|